Ebstein anomaly – epidemiology, signs, symptoms, treatment

1. ๐Ÿ” Definition & Pathophysiology

Ebstein anomaly is a rare congenital cardiac defect characterized by downward (apical) displacement of the septal and posterior leaflets of the tricuspid valve into the right ventricle, resulting in โ€œatrializationโ€ of a portion of the RV and dilatation of the right atrium. Leaflets may be tethered or fenestrated, with an enlarged annulus and variable chordal anomalies. This displacement typically exceeds 8โ€ฏmm/mยฒ on echocardiographic assessment Pediatrics+13NCBI+13UCSF Health+13.

Consequences include:

  • Severe tricuspid regurgitation
  • Abnormal RV function and chamber geometry
  • Enlarged RA and atrialized RV
  • Frequent right-to-left shunts via ASD or PFO
  • High incidence (25โ€“65%) of accessory pathways/WPW, leading to arrhythmias WikipediaNCBI+1Wikipedia+1

2. ๐ŸŒ Epidemiology

  • Incidence ~0.2โ€“0.7 per 10,000 live births (~0.3โ€“0.6% of congenital heart disease) NCBI.
  • Gender prevalence is equal. Slightly higher incidence in Caucasians.
  • Majority are sporadic; familial recurrence: ~6% from mothers, ~1% from fathers AHA Journals.
  • Associated with chromosomal anomalies (15q duplications, MYH7, NKX2โ€‘5) NCBI.

3. ๐Ÿšผ Etiology & Risk Factors


4. ๐Ÿฉบ Clinical Presentation

  • Highly variableโ€”from asymptomatic adults to neonates with cyanosis, heart failure, or shock NCBI.
  • Neonates: may present prenatally or shortly after birth with cyanosis and perinatal mortality ~45% in severe cases .
  • Adults: present with exertional dyspnea, palpitations, fatigue, cyanosis, edema, or syncope NCBI.
  • Arrhythmias are common; risk of sudden cardiac death exists .

5. ๐Ÿงช Diagnostic Evaluation

  • ECG: tall โ€œHimalayanโ€ P waves (RA enlargement), right-axis deviation, WPW features, first-degree AV block, RBBB pattern Wikipedia.
  • Echocardiography: first-lineโ€”quantifies tricuspid displacement (>8โ€ฏmm/mยฒ), assesses regurgitation, RV function, shunts PMC+4NCBI+4Wikipedia+4.
  • Cardiac MRI: for detailed anatomy, RV volumes, and pre-surgical planning.
  • Chest X-ray: RA enlargement, cardiomegaly.
  • Holter/EP studies: evaluate arrhythmias and plan intervention.

6. ๐Ÿ“ˆ Natural History & Prognosis

  • Prognosis correlates with the severity of leaflet displacement, RV dysfunction, and tricuspid regurgitation .
  • Celermajer index (RA + atrialized RV area vs. functional cardiac chambers) predicts mortality: Grade I (<0.5) 0%, Grade III higher NCBI+1Cambridge University Press & Assessment+1.
  • Left untreated: 1-year survival ~90%, falls to ~40% by 20 years .
  • Surgical outcomes improved: post-cone repair survival ~98% at 1 year, ~76% at 20 years; reoperation ~2% at 6 years NCBI.

7. ๐Ÿฅ Management

A. Surveillance

  • All patients require lifelong cardiology care, preferably by ACHD specialists.
  • Serial echocardiography (annually or per symptom progression) UpToDate.

B. Medical Therapy

  • Congestive symptoms: diuretics, ACE inhibitors/ฮฒ-blockers as needed.
  • Arrhythmias: accessory pathwayโ€“mediated SVT โ†’ procainamide or class Ic agents; AV nodal blockers contraindicated .
  • WPW/arrhythmias: early catheter ablation or surgical cryoablation, especially before valve repair NCBI.
  • Anticoagulation: for AF or paradoxical embolism risk NCBI.
  • Endocarditis prophylaxis: for uncorrected anomalies or post-valve surgery .

C. Surgical Indications & Techniques

Per 2025 AATS consensus aats.org+2PubMed+2J Thorac Cardiovasc Surg+2, refer for surgery when:

  • Symptomatic NYHA IIโ€“IV, RV dysfunction, cyanosis, cardiomegaly (CTR >65%).
  • Severe tricuspid regurgitation, large ASD with cyanosis, arrhythmias failing medical therapy.

Preferred surgical strategy:

  • Cone reconstruction of the tricuspid valveโ€”standard in skilled centers, with excellent long-term outcomes NCBI+1Wikipedia+1ScienceDirect+1aats.org+1.
  • Neonatal management (AATS 2024): emergent Starnes procedure or modified biventricular repair depending on clinical status PubMed+2aats.org+2PubMed+2.
  • Valve replacement reserved for non-repairable valves.

8. ๐Ÿ’ก Key Clinical Pearls

  • Presentation and progression vary greatly; clinical judgment guided by anatomy, function, and symptoms.
  • Arrhythmia management is essential to reduce sudden cardiac death risk.
  • Early valve repair before irreversible RV dysfunction yields better outcomes.
  • Multidisciplinary care (ACHD cardiology, electrophysiology, cardiothoracic surgery) is critical.

๐Ÿงญ Summary Table

FeatureHighlights
DiagnosisEchocardiogram (primary), ECG, CMRI, Holter, EP studies
MonitoringLifelong surveillance; annual echo unless mild
Medical ManagementDiuretics, anti-arrhythmics, ablation, anticoagulation
SurgeryCone repair, neonatal procedures (Starnes), valve replacement when needed
PrognosisVariable; improved with early repair and arrhythmia control

Author

    Leave a Reply